108
Y. Zhang et al. / Journal of Molecular Catalysis B: Enzymatic 110 (2014) 100–110
(m, 1H), 1.71–1.60 (m, 3H), 1.39–1.33 (m, 1H); 13C NMR (100 MHz,
CDCl3): ı 214.12, 211.81, 146.50, 143.98, 142.05, 139.58, 138.78,
136.28, 65.96, 54.20, 42.35, 30.16, 27.49, 24.49. Enantiomeric
excess was determined by HPLC with a CHIRALPAK AD-H col-
umn (90:10 hexane:2-propanol), 25 ◦C, 215 nm, 0.5 mL/min; major
enantiomer tr = 14.0 min, minor enantiomer tr = 17.1 min.
HPLC with a CHIR-ALPAK AD-H column (98:2 hexane:2-propanol),
25 ◦C, 220 nm, 1.0 mL/min; major enantiomer tr = 28.6 min, minor
enantiomer tr = 32.8 min.
4.3.10. 2-((4-Bromophenyl)(hydroxy)methyl)cyclohexanone (j)
Yellow solid; mp: 114–117 ◦C; 1H NMR (400 MHz, CDCl3): ı
7.47 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.3 Hz, 2H), 5.34 (s, 0.05H), 4.75
(dd, J = 8.7, 2.7 Hz, 0.99H), 3.99 (d, J = 2.7 Hz, 1H), 2.62–2.51 (m,
1H), 2.49–2.45 (m, 1H), 2.39–2.34 (m, 1H), 2.11–2.07 (m, 1H),
1.88–1.74 (m, 1H), 1.71–1.50 (m, 3H), 1.31–1.27 (m, 1H); 13C NMR
(101 MHz, CDCl3): ı 215.22, 214.52, 140.03, 131.47, 128.73, 121.71,
74.17, 57.32, 42.65, 30.75, 27.72, 24.70. Enantiomeric excess was
determined by HPLC with a CHIRALPAK AD-H column (90:10
hexane:2-propanol), 25 ◦C, 220 nm, 0.5 mL/min; major enantiomer
tr = 30.3 min, minor enantiomer tr = 26.1 min.
4.3.5.
2-(Hydroxy(4-(trifluoromethyl)phenyl)methyl)cyclohexanone (e)
White solid; mp: 79–81 ◦C; 1H NMR (400 MHz, CDCl3): ı 7.62
(d, J = 8.1 Hz, 2H), 7.46 (d, J = 8.0 Hz, 2H), 5.46 (s, 0.13H), 4.87 (d,
J = 8.6 Hz, 0.87H), 4.08 (s, 1H), 2.65–2.58 (m, 1H), 2.52–2.49 (m, 1H),
2.41–2.34 (m, 1H), 2.14–2.09 (m, 1H), 1.84–1.81 (m, 1H), 1.73–1.67
(m, 1H), 1.61–1.55 (m, 2H), 1.40–1.33 (m, 1H); 13C NMR (100 MHz,
CDCl3): ı 215.12, 214.41, 144.96, 130.22, 129.89, 127.37, 126.08,
125.31, 74.26, 57.26, 42.67, 30.76, 27.71, 24.70. Enantiomeric
excess was determined by HPLC with a CHIRALPAK AD-H column
(98:2 hexane:2-propanol), 25 ◦C, 220 nm, 1.0 mL/min; major enan-
tiomer tr = 39.2 min, minor enantiomer tr = 27.7 min.
4.3.11. 4-(Hydroxy(2-oxocyclohexyl)methyl)benzonitrile (k)
Yellow solid; mp: 69–70 ◦C; 1H NMR (400 MHz, CDCl3): ı 7.64 (d,
J = 6.9 Hz, 2H), 7.46–7.42 (m, 2H), 5.43 (s, 0.17H), 4.84 (d, J = 8.4 Hz,
0.84H), 4.07 (s, 1H), 2.61–2.54 (m, 1H), 2.51–2.47 (m, 1H), 2.40–2.34
(m, 1H), 2.13–2.10 (m, 1H), 1.82 (d, J = 12.9 Hz, 1H), 1.71–1.50
(m, 3H), 1.40–1.25 (m, 1H); 13C NMR (100 MHz, CDCl3): ı 214.75,
214.03, 146.40, 132.09, 127.77, 118.77, 111.68, 74.19, 57.13, 42.62,
30.72, 27.73, 24.72. Enantiomeric excess was determined by HPLC
with a CHIRALPAK AD-H column (80:20 hexane:2-propanol), 25 ◦C,
220 nm, 0.5 mL/min; major enantiomer tr = 26.2 min, minor enan-
tiomer tr = 21.7 min.
4.3.6. 2-((4-Chlorophenyl)(hydroxy)methyl)cyclohexanone (f)
Yellow solid; mp: 91–93 ◦C; 1H NMR (400 MHz, CDCl3):ı
7.35–7.32 (t, J = 6.2 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 5.38 (s, 0.19H),
4.79 (d, J = 8.7 Hz, 0.86H), 4.01 (s, 1H), 2.64–2.55 (m, 1H), 2.53–2.48
(m, 1H), 2.42–2.33 (m, 1H), 2.19–2.04 (m, 1H), 1.91–1.77 (m, 1H),
1.70–1.56 (m, 3H), 1.35–1.26 (m, 1H); 13C NMR (100 MHz, CDCl3): ı
215.23, 214.52, 139.51, 133.57, 128.52, 128.38, 74.11, 57.36, 42.65,
30.75, 27.72, 24.70. Enantiomeric excess was determined by HPLC
with a CHIRALPAK AD-H column (90:10 hexane:2-propanol), 25 ◦C,
221 nm, 0.5 mL/min; major enantiomer tr = 27.9 min, minor enan-
tiomer tr = 24.4 min.
4.3.12. 2-(Hydroxy(2-nitrophenyl)methyl)cyclohexanone (l)
Yellow solid; mp: 97–99 ◦C; 1H NMR (400 MHz, CDCl3): ı 7.85
(d, J = 8.1 Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.64 (t, J = 7.4 Hz, 1H), 7.43
(t, J = 7.7 Hz, 1H), 5.96 (s, 0.08H), 5.45 (d, J = 7.0 Hz, 0.94H), 4.19
(s, 1H), 2.84–2.70 (m, 1H), 2.46 (d, J = 12.9 Hz, 1H), 2.40–2.28 (m,
1H), 2.11–2.05 (m, 1H), 1.86–1.58 (m, 5H); 13C NMR (100 MHz,
CDCl3): ı 214.89, 213.95, 148.75, 136.60, 133.04, 129.00, 128.39,
124.06, 69.76, 57.31, 42.82, 31.11, 27.75, 24.97. Enantiomeric
excess was determined by HPLC with a CHIRALCEL OD-H column
(95:5 hexane:2-propanol), 25 ◦C, 254 nm, 0.5 mL/min; major enan-
tiomer tr = 30.6 min, minor enantiomer tr = 35.8 min.
4.3.7. 2-((2,4-Dichlorophenyl)(hydroxy)methyl)cyclohexanone
(g)
White solid; mp: 89–91 ◦C; 1H NMR (400 MHz, CDCl3) ı 7.51
(d, J = 8.4 Hz, 1H), 7.37 (d, J = 2.1 Hz, 1H), 7.32–7.28 (m, 1H), 5.31
(dd, J = 8.0, 3.6 Hz, 1H), 4.08 (d, J = 3.9 Hz, 1H), 2.67–2.61 (m, 1H),
2.50–2.47 (m, 1H), 2.41–2.27 (m, 1H), 2.13–2.09 (m, 1H), 1.85 (d,
J = 6.0 Hz, 1H), 1.71–1.55 (m, 4H); 13C NMR (100 MHz, CDCl3): ı
215.10, 137.82, 133.79, 133.50, 129.26, 128.90, 127.63, 70.09, 57.51,
42.71, 30.37, 27.76, 24.89. Enantiomeric excess was determined by
HPLC with a CHIRALPAK AS-H column (90:10 hexane:2-propanol),
25 ◦C, 220 nm, 1.0 mL/min; major enantiomer tr = 11.0 min, minor
enantiomer tr = 9.4 min.
4.3.13. 2-(Hydroxy(3-nitrophenyl)methyl)cyclohexanone (m)
Yellow solid; mp: 110–111 ◦C; 1H NMR (400 MHz, CDCl3): ı
8.31–8.06 (m, 2H), 7.68 (d, J = 7.5 Hz, 1H), 7.53 (t, J = 7.9 Hz, 1H),
5.48 (s, 0.08H), 4.90 (d, J = 8.4 Hz, 0.93H), 4.13 (s, 1H), 2.72–2.57 (m,
1H), 2.51 (d, J = 13.8 Hz, 1H), 2.45–2.31 (m, 1H), 2.13 (d, J = 10.9 Hz,
1H), 1.84 (d, J = 12.7 Hz, 1H), 1.73–1.34 (m, 4H); 13C NMR (100 MHz,
CDCl3): ı 214.81, 214.03, 148.28, 143.30, 133.20, 129.21, 122.84,
122.03, 73.99, 57.12, 42.62, 30.73, 27.62„ 24.69. Enantiomeric
excess determined by HPLC with a CHIRALPAK AD-H column (95:5
hexane:2-propanol), 25 ◦C, 254 nm, 0.7 mL/min; major enantiomer
tr = 44.0 min, minor enantiomer tr = 56.0 min.
4.3.8. 2-((2,6-Dichlorophenyl)(hydroxy)methyl)cyclohexanone
(h)
Yellow solid; mp: 128–129 ◦C; 1H NMR (400 MHz, CDCl3): ı 7.33
(d, J = 8.0 Hz, 2H), 7.17 (t, J = 7.9 Hz, 1H), 5.86 (dd, J = 9.5, 2.9 Hz, 1H),
3.68 (d, J = 3.1 Hz, 1H), 3.60–3.44 (m, 1H), 2.54 (d, J = 13.7 Hz, 1H),
2.49–2.35 (m, 1H), 2.12 (d, J = 9.5 Hz, 1H), 1.85 (d, J = 11.5 Hz, 1H),
1.79–1.61 (m, 2H), 1.44–1.35 (m, 2H). 13C NMR (100 MHz, CDCl3):
ı 214.36, 135.68, 134.73, 129.33, 70.55, 53.65, 42.43, 29.87, 27.63,
24.69. Enantiomeric excess was determined by HPLC with a CHI-
RALPAK AS-H column (98:2 hexane:2-propanol), 25 ◦C, 220 nm,
0.5 mL/min; major enantiomer tr = 53.0 min, minor enantiomer
tr = 45.2 min.
4.3.14. 2-(Hydroxy(4-nitrophenyl)methyl)cyclohexanone (n)
Yellow solid; mp: 96–97 ◦C; 1H NMR (400 MHz, CDCl3): ı 8.23
(d, J = 7.6 Hz, 2H), 7.53 (d, J = 7.7 Hz, 2H), 5.51 (s, 0.19H), 4.92 (d,
J = 8.2 Hz, 0.88H), 4.09 (s, 1H), 2.75–2.57 (m, 1H), 2.52 (d, J = 13.7 Hz,
1H), 2.43–2.35 (m, 1H), 2.14 (d, J = 10.6 Hz, 1H), 1.85 (d, J = 12.4 Hz,
1H), 1.73–1.51 (m, 4H); 13C NMR (100 MHz, CDCl3): ı 214.68,
213.96, 148.40, 127.87, 123.48, 73.97, 57.17, 42.62, 30.75, 27.72,
25.90, 24.72. Enantiomeric excess was determined by HPLC with a
CHIRALPAK AD-H column (93:7 hexane:2-propanol), 25 ◦C, 254 nm,
1.0 mL/min; major enantiomer tr = 39.8 min, minor enantiomer
tr = 29.1 min.
4.3.9. 2-((2-Bromophenyl)(hydroxy)methyl)cyclohexanone (i)
Yellow solid; mp: 93–95 ◦C; 1H NMR (400 MHz, CDCl3): ı
7.56–7.52 (m, 2H), 7.39–7.35 (m, 1H), 7.17–7.06 (m, 1H), 5.67 (s,
0.04H), 5.32 (d, J = 7.9 Hz, 0.97H), 4.09 (s, 1H), 2.74–2.67 (m, 1H),
2.50–2.45 (m, 1H), 2.41–2.28 (m, 1H), 2.18–2.03 (m, 1H), 1.93–1.80
(m, 1H), 1.77–1.51 (m, 4H); 13C NMR (100 MHz, CDCl3): ı 215.25,
214.71, 140.73, 132.50, 129.11, 128.47, 127.87, 123.37, 72.85, 57.67,
42.75, 30.56, 27.83, 24.96. Enantiomeric excess was determined by